Continuation Electroconvulsive Therapy vs Pharmacotherapy for Relapse Prevention in Major Depression
Author(s) -
Charles H. Kellner,
Rebecca G. Knapp,
Georgios Petrides,
Teresa A. Rummans,
Mustafa M. Husain,
Keith G. Rasmussen,
Martina Mueller,
Hilary J. Bernstein,
Kevin O’Connor,
Glenn E. Smith,
Melanie M. Biggs,
Samuel H. Bailine,
Chitra Malur,
Eunsil Yim,
Shawn M. McClintock,
Shirlene Sampson,
Max Fink
Publication year - 2006
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.63.12.1337
Subject(s) - electroconvulsive therapy , depression (economics) , randomized controlled trial , medicine , pharmacotherapy , bipolar disorder , psychiatry , psychology , lithium (medication) , economics , macroeconomics , electroconvulsive shock
Although electroconvulsive therapy (ECT) has been shown to be extremely effective for the acute treatment of major depression, it has never been systematically assessed as a strategy for relapse prevention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom